If you need more lookups,
subscriptions start at $34 USD/month.
Bin Chen Location
Beijing, China
Bin Chen Work
Chief Executive Officer @ (July 2021 - Present)
Chief Executive Officer and Co-foubder @ Syngentech (July 2019 - July 2021)
Head of Translational Sciences Asia @ (April 2018 - July 2019)
Director of Janssen BioTherapeutics @ (July 2017 - March 2018)
Director and Early Development Scientific Leader of Janssen BioTherapeutics @ (February 2015 - July 2017)
Scientific Director of Clinical Pharmacology @ (July 2008 - February 2015)
Scientist of PKDM @ (November 2005 - July 2008)
Postdoctoral Fellow @ (August 2004 - November 2005)
Bin Chen Education
University of Nevada-Las Vegas
Ph.D. (Biomedical Engineering)
2000-2004
Nanjing University of Aeronautics and Astronautics
BS (Mechanical Engineering)
1994-1998
Bin Chen Skills
Clinical Development
Clinical Pharmacology
Clinical Trials
Drug Delivery
Modeling
PK/PD
Pharmacokinetics
Pharmacometrics
Regulatory Submissions
Pharmacodynamics
Drug Development
GLP
Biotechnology
Translational Medicine
Immunology
Biopharmaceuticals
Biotherapeutics
Early Development
Strategy
Biochemistry
Development
Data Analysis
Bin Chen Summary
Bin Chen, based in Beijing, China, is currently a Chief Executive Officer at Huahui Health. Bin Chen brings experience from previous roles at Syngentech, Bayer and The Janssen Pharmaceutical Companies of Johnson & Johnson. Bin Chen holds a 2000 - 2004 Ph.D. in Biomedical Engineering @ University of Nevada-Las Vegas. With a robust skill set that includes Clinical Development, Clinical Pharmacology, Clinical Trials, Drug Delivery, Modeling and more. Bin Chen has 3 mobile phone numbers on RocketReach.
Looking for a different Bin Chen?
Find contact details for 700 million professionals.